- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Norland acquires ultrasound technology
Bone densitometry vendor Norland Medical Systems of White Plains,NY, has acquired rights to an ultrasound-based bone measurementsystem through an agreement with Vitel, a Texas company affiliatedwith the University of Texas Southwestern Medical Center in
Bone densitometry vendor Norland Medical Systems of White Plains,NY, has acquired rights to an ultrasound-based bone measurementsystem through an agreement with Vitel, a Texas company affiliatedwith the University of Texas Southwestern Medical Center in Dallas.
Vitel is developing bone measurement devices using a technologyit has licensed from the university called ultrasound criticalangle reflection (UCR). UCR technology can provide a quantitativeassessment of bone quality, according to Norland, making possiblean independent assessment of both cortical and trabecular bone.
Norland acquired exclusive worldwide rights to all productsdeveloped by Vitel and has agreed to make an equity investmentin Vitel. An ultrasound-based bone densitometry system would complementx-ray-based systems marketed by Norland and its Dove Medical Systemssubsidiary (SCAN 4/10/96).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
